Y. Ofran
AuthID: R-00J-P20
1
TÃTULO: The QUAZAR AML-001 maintenance trial: Results of a phase III international, randomized, double-blind, placebo-controlled study of oral CC-486 in patients with Acute Myeloid Leukemia (AML) in first remission
AUTORES: Doehner, H; Wei, AH; Pocock, C; Montesinos, P; Dombret, H; Ravandi, F; Sayar, H; Jang, JH; Porkka, K; Selleslag, D; Sandhu, I; Turgut, M; Giai, V; Ofran, Y; Cakar, MK; Botelho de Sousa, AB; Rybka, J; Frairia, C; Borin, L; Beltrami, G; ...Mais
PUBLICAÇÃO: 2020, FONTE: ONCOLOGY RESEARCH AND TREATMENT, VOLUME: 43, NÚMERO: SUPPL 4
AUTORES: Doehner, H; Wei, AH; Pocock, C; Montesinos, P; Dombret, H; Ravandi, F; Sayar, H; Jang, JH; Porkka, K; Selleslag, D; Sandhu, I; Turgut, M; Giai, V; Ofran, Y; Cakar, MK; Botelho de Sousa, AB; Rybka, J; Frairia, C; Borin, L; Beltrami, G; ...Mais
PUBLICAÇÃO: 2020, FONTE: ONCOLOGY RESEARCH AND TREATMENT, VOLUME: 43, NÚMERO: SUPPL 4
INDEXADO EM: 
WOS
WOS